EXAGEN INC. (XGN) Operating Margin
- Operating margin · 12 months: Value -18.58%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -18.58% | Operating income / revenue. Period ending 2026-06-30. $-13.21M ÷ $71.12M × 100 ≈ -18.58% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -13.21M USD | Operating Income (Loss) |
| Revenue | 71.12M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 29.42M USD | Cost of Goods and Services Sold |
| Research and development | 6.47M USD | Research and Development Expense |
| Selling, general and administration | 48.45M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-13.21M | $71.12M | $29.42M | $6.47M | $48.45M | -18.58% |
| 2026-03-31 | $-14.12M | $68.38M | $28.50M | $6.52M | $47.48M | -20.65% |
| 2025-12-31 | $-14.07M | $66.58M | $27.78M | $6.25M | $46.62M | -21.13% |
| 2025-09-30 | $-12.48M | $63.60M | $25.53M | $6.15M | $44.40M | -19.62% |
| 2025-06-30 | $-14.04M | $58.86M | $23.89M | $5.90M | $43.11M | -23.85% |
| 2025-03-31 | $-14.00M | $56.72M | $23.09M | $5.60M | $42.03M | -24.68% |
| 2024-12-31 | $-13.64M | $55.64M | $22.53M | $5.38M | $41.37M | -24.51% |
| 2024-09-30 | $-15.40M | $55.75M | $22.97M | $4.79M | $43.38M | -27.62% |
| 2024-06-30 | $-15.81M | $56.66M | $23.16M | $4.71M | $44.60M | -27.90% |
| 2024-03-31 | $-18.13M | $55.73M | $22.98M | $4.80M | $46.09M | -32.54% |
| 2023-12-31 | $-22.84M | $52.55M | $23.09M | $4.87M | $47.43M | -43.46% |
| 2023-09-30 | $-32.18M | $51.62M | $23.78M | $6.49M | $48.02M | -62.34% |
| 2023-06-30 | $-34.93M | $52.93M | $24.08M | $7.47M | $50.80M | -65.99% |
| 2023-03-31 | $-44.08M | $46.40M | $24.32M | $8.90M | $51.75M | -95.00% |
| 2022-12-31 | $-46.05M | $45.56M | $24.21M | $9.88M | $52.02M | -101.07% |
| 2022-09-30 | $-37.81M | $45.41M | $22.84M | $9.38M | $51.01M | -83.26% |
| 2022-06-30 | $-35.15M | $44.30M | $22.32M | $8.73M | $48.38M | -79.34% |
| 2022-03-31 | $-28.18M | $48.11M | $21.69M | $7.94M | $46.65M | -58.58% |
| 2021-12-31 | $-24.07M | $48.30M | $20.59M | $7.24M | $44.54M | -49.83% |
| 2021-09-30 | $-20.57M | $48.28M | $19.98M | $6.20M | $42.67M | -42.62% |
| 2021-06-30 | $-17.86M | $46.80M | $18.84M | $5.48M | $40.34M | -38.15% |
| 2021-03-31 | $-15.53M | $42.98M | $16.73M | $4.34M | $37.45M | -36.14% |
| 2020-12-31 | $-15.19M | $41.98M | $16.56M | $3.57M | $37.03M | -36.18% |
| 2020-09-30 | $-15.28M | $39.52M | $16.82M | $2.97M | $35.02M | -38.67% |
| 2020-06-30 | $-13.65M | $39.19M | $17.26M | $2.46M | $33.12M | -34.84% |
| 2020-03-31 | $-12.65M | $40.71M | $18.91M | $2.30M | $32.15M | -31.06% |
| 2019-12-31 | $-9.30M | $40.39M | $18.81M | $2.18M | $28.70M | -23.02% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-4.88M | $32.44M | $15.38M | $2.13M | $19.68M | -15.04% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |